The Clinical Value of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management

Dr. Philip Silkoff discusses the burden of asthma and the challenges physicians face with managing and diagnosing it.

Meet the Host

Featured Guest

Philip E. Silkoff, MBBS
Philip E. Silkoff, MBBS

Dr. Silkoff is an experienced pulmonologist who has served as the Chief Medical Officer for Third Pole Therapeutics; Senior Medical Director at Janssen R&D, a pharmaceutical company of Johnson & Johnson; and Medical Director at AstraZeneca. He also was an associate professor at National Jewish and the Clinical Director of the adult ambulatory pulmonary services, with an appointment as associate professor of medicine in the Department of Medicine at the University of Colorado Health Sciences Center. In his industry roles, he oversaw multiple clinical studies in asthma, COPD, interstitial pulmonary fibrosis and sarcoidosis. He currently counsels industry and serves as a preceptor attending physician for the Temple Lung Center Fellows Clinic at Temple University Hospital in Philadelphia, PA. Dr. Silkoff earned his MBBS in respiratory medicine from University College London and an MBBS in medicine from the University of London.